Ranolazine
Ranolazine is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Ranolazine; Generic name: RANOLAZINE; Drug class: Anti-anginal [EPC].
| Brand name | Ranolazine |
|---|---|
| Generic name | RANOLAZINE |
| Drug class | Anti-anginal [EPC] |
| Manufacturer | Viona Pharmaceuticals Inc |
| Used for | 1 INDICATIONS AND USAGE Ranolazine extended-release tablet is indicated for the treatment of chronic angina. Ranolazine extended-release tablet may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine extended-release tablet is an antianginal indicated for the treatment of chronic angina. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION 500 mg twice daily and increase to 1000 mg twice daily, based on clinical symptoms ( 2.1 ) 2.1 Dosing Information Initiate ranolazine extended-release tablet dosing at 500 mg twice daily and increase to 1000 mg twice daily, as needed, based on clinical symptoms. Take ranolazine extended-release tablet with or without meals. Swallow ranolazine extended-release tablet whole; do not crush, break, or chew. The maximum recommended daily dose of ranolazine extended-release |
| Active ingredient(s) | RANOLAZINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00979fb3-d70f-493d-94ca-2914cbadaa9d |